MarketPeel
Insider Trading Intelligence
JB

Jeffrey Allen Bailey

AUPH
DIRECTOR · AURINIA PHARMACEUTICALS INC. · CIK 0001500210
FILING MIX · LIFETIME75%/25%
BUYS
12
SELLS
4
TOTAL VALUE
$124.7K
COMPANIES
5
ACTIVE SINCE
Sep 2020
HOLDINGS NOW
25,571
AVG SELL PX
$11.14
TRADE KIND
SHOWING 16 / 16
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizons · 1 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Jeffrey Allen Bailey, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+100.00%+0.97%+2.05%-1.08%-1.00%
14d5+80.00%+4.71%+3.61%+1.10%+1.70%
30d5+80.00%+7.19%+5.46%+1.73%-2.21%
60d5+100.00%+6.28%+7.45%-1.16%-1.50%
90d5+100.00%+11.90%+11.22%+0.67%+2.21%
180d5+100.00%+16.73%+16.48%+0.25%+0.98%
1y5+80.00%+46.48%+33.42%+13.06%+3.62%
2y5(1 pending)+75.00%+6.19%+17.21%-11.02%-10.74%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AUPH · 23,931 shares · as of Jun 4, 2026
09,37118,74328,11437,485202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 12 buys / 4 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AUPH
AURINIA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
23,93123,931Jun 4, 2026Jun 8, 2026View →
AUPH
AURINIA PHARMACEUTICALS INC.
SALE
2,716$15.68$42.6K22,775Nov 21, 2025Nov 24, 2025View →
AUPH
AURINIA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
37,48537,485May 16, 2025May 16, 2025View →
AUPH
AURINIA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
18,64118,641Nov 21, 2024Nov 25, 2024View →
AUPH
AURINIA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
12,13525,491Nov 21, 2024Nov 25, 2024View →
AUPH
AURINIA PHARMACEUTICALS INC.
SALE
4,557$8.43$38.4K13,356Nov 11, 2024Nov 12, 2024View →
AUPH
AURINIA PHARMACEUTICALS INC.
PURCHASE
17,91317,913Nov 8, 2024Nov 12, 2024View →
AUPH
AURINIA PHARMACEUTICALS INC.
SALE
17,9130Nov 8, 2024Nov 12, 2024View →
AUPH
AURINIA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
17,91317,913Aug 18, 2023Aug 21, 2023View →
AUPH
AURINIA PHARMACEUTICALS INC.
PURCHASEGRANT
Stock grant
28,95928,959Aug 18, 2023Aug 21, 2023View →
THW
ABRDN WORLD HEALTHCARE FUND
PURCHASE
245$14.26$3.5K980Apr 6, 2021Apr 8, 2021View →
THW
ABRDN WORLD HEALTHCARE FUND
SALE
7350Apr 6, 2021Apr 8, 2021View →
THW
ABRDN WORLD HEALTHCARE FUND
PURCHASE
710$14.18$10.1K710Sep 23, 2020Sep 23, 2020View →
HQH
ABRDN HEALTHCARE INVESTORS
PURCHASE
490$20.39$10.0K490Sep 23, 2020Sep 23, 2020View →
THQ
ABRDN HEALTHCARE OPPORTUNITIES FUND
PURCHASE
570$17.68$10.1K570Sep 23, 2020Sep 23, 2020View →
HQL
ABRDN LIFE SCIENCES INVESTORS
PURCHASE
580$17.28$10.0K580Sep 22, 2020Sep 23, 2020View →
Other insiders · AUPH
Loading peer insiders…
About this filer
CIK 0001500210
ROLE
Director
PRIMARY
AUPH
COMPANIES
5
ACTIVE SINCE
Sep 2020
MARKETPEEL · /INSIDER/0001500210DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback